Hu, X., Fatima, S., Chen, M., Huang, T., Chen, Y. W., Gong, R., . . . Bian, Z. (2021). Dihydroartemisinin is potential therapeutics for treating late-stage CRC by targeting the elevated c-Myc level. Nature Publishing Group.
Chicago Style (17th ed.) CitationHu, Xianjing, et al. Dihydroartemisinin Is Potential Therapeutics for Treating Late-stage CRC by Targeting the Elevated C-Myc Level. Nature Publishing Group, 2021.
MLA (8th ed.) CitationHu, Xianjing, et al. Dihydroartemisinin Is Potential Therapeutics for Treating Late-stage CRC by Targeting the Elevated C-Myc Level. Nature Publishing Group, 2021.
Warning: These citations may not always be 100% accurate.